In January 2016, the Lancet confirmed what the medical world has been dreading: a bacterial organism with essentially unfettered protection against all the antibiotics available to control it has been...

Researchers at Duke Health are fine-tuning a test that can determine whether a respiratory illness is caused by infection from a virus or bacteria so that antibiotics can be more precisely prescribed. The...

By

A novel class of antimicrobials that inhibits the function of a key disease-causing component of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the...

By

Cempra, Inc. announced recently that the U.S. Food and Drug Administration (FDA) has granted a qualified infectious disease product (QIDP) designation to Cempra’s investigational antibiotic product...

By

New recommendations from the Centers for Disease Control and Prevention (CDC) advise all nursing homes to improve antibiotic prescribing practices and reduce their inappropriate use to protect residents...

By

Novel drug candidate, MRX-I, an oral oxazolidinone showed positive top-line results from the first Phase 2 clinical study in China, according to biopharmaceutical company, MicuRx Pharmaceuticals,...

By

The Centers for Disease Control and Prevention (CDC) published recently a short, 2-minute video on  how antibiotic-resistant germs are spreading between healthcare facilities, even those that are practicing...

In a systematic review of six in-person trials in Asian populations, the Cochrane Upper GI and Pancreatic Diseases Group showed that antibiotics given to individuals testing positive for Helicobacter pylori...

By

The antibiotic meropenem was approved by the U. S. Food and Drug Administration for treating abdominal infections in children less than 3 months of age. The approval came after a study by a National Institutes...

By

It’s a device that could transform doctors’ ability to treat infections: a test for antibiotic resistance that works in just one hour — instead of several days. We live in fear of ‘superbugs’:...